WINALL(300087)
Search documents
荃银高科(300087) - 2022 Q3 - 季度财报
2022-10-26 16:00
Financial Performance - The company's revenue for Q3 2022 reached ¥570,565,404.15, representing a 9.41% increase compared to the previous quarter and a 28.09% increase year-to-date[6]. - The net profit attributable to shareholders was ¥7,347,291.27, showing a decrease of 13.64% from the previous quarter, but a significant increase of 4,043.42% year-to-date[6]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥29,920,273.91, reflecting a decrease of 782.82% from the previous quarter and an 86.85% decline year-to-date[6]. - Revenue for the first nine months of 2022 reached ¥1,535,963,577.87, an increase of 28.09% compared to ¥1,199,165,871.05 in the same period of 2021[12]. - The company achieved operating revenue of RMB 153,596.36 million in 2022, representing a year-on-year growth of 28.09%[21]. - Net profit attributable to shareholders reached RMB 3,782.58 million, an increase of RMB 3,878.50 million compared to the same period last year[21]. Assets and Liabilities - The total assets as of the end of Q3 2022 amounted to ¥4,901,997,693.83, which is a 38.54% increase compared to the end of the previous year[6]. - Total liabilities reached ¥3,126,589,533.33, up from ¥1,887,436,723.89, indicating a rise of 65.73%[30]. - Total equity attributable to shareholders of the parent company was ¥1,381,539,371.28, slightly up from ¥1,373,411,767.86[30]. - The company reported a long-term investment in equity of ¥11,102,457.76, compared to ¥1,962,544.07 in the previous period, showing a substantial increase[30]. Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥546,613,435.06, marking a 13.19% increase[6]. - Net cash inflow from operating activities was ¥546,613,435.06, reflecting a 13.19% increase from ¥482,912,394.58 year-on-year[12]. - Cash flow from investment activities saw a significant increase of 317.23%, totaling ¥1,646,194,165.42, mainly due to the redemption of financial products during the reporting period[12]. - The company reported a cash outflow from investment activities totaling ¥1,602,793,327.23, compared to ¥1,135,255,168.58 in the previous period, reflecting an increase of about 41%[41]. Expenses - Operating costs increased by 29.86% to ¥1,229,411,215.9 from ¥946,755,960.96 year-on-year, primarily due to increased sales in the seed industry[12]. - Financial expenses decreased by 76.70% to ¥4,362,624.48, attributed to increased foreign exchange gains and interest income compared to the previous year[12]. - Sales expenses increased to 134,561,051.62 from 105,490,539.52, reflecting a growth of approximately 27.6%[34]. - Research and development expenses rose to 41,380,656.37, up from 38,530,023.83, indicating an increase of about 4.8%[34]. Investments and Acquisitions - The company intends to acquire a 60% stake in Xinjiang Jinfengyuan Seed Industry Co., Ltd. for RMB 20,673.762 million, with a proposed merger loan of up to RMB 12,000 million[23]. - The company approved a financial derivatives business to mitigate risks related to exchange rates and commodity price fluctuations, with a maximum limit of RMB 65,000 million[23]. - Investment income surged by 186.38% to ¥10,344,288.46, driven by higher returns from financial products compared to the same period last year[12]. Shareholder Information - The basic earnings per share for Q3 2022 was ¥0.0110, down 45.54% from the previous quarter, but up 2,565.22% year-to-date[6]. - The total number of restricted shares at the end of the period was 37,490,240, with no shares released from restriction during the period[20]. - The company reduced the amortization expense of the first employee stock ownership plan by RMB 2,531.37 million compared to the previous year[21]. Future Plans - The company plans to use up to RMB 45,000 million of idle raised funds for cash management, with a maximum investment period of 6 months[23]. - The company plans to continue expanding its market presence and investing in new product development[28].
荃银高科(300087) - 2022 Q2 - 季度财报
2022-08-25 16:00
Financial Performance - The company reported a total revenue of 1.2 billion CNY for the first half of 2022, representing a year-on-year increase of 15%[19]. - The company achieved operating revenue of ¥965,398,173.72, representing a 42.46% increase compared to the same period last year[27]. - Net profit attributable to shareholders reached ¥30,478,555.86, a significant increase of 421.95% year-on-year[27]. - The net profit after deducting non-recurring gains and losses was ¥15,840,281.30, up 232.92% from the previous year[27]. - The net cash flow from operating activities was ¥175,475,736.66, a 208.95% increase compared to the same period last year[27]. - Seed sales revenue amounted to ¥55,096.43 million, reflecting a 60.65% increase year-on-year, with sales volume up 67.25%[37]. - The company’s rice seed revenue was ¥39,247.02 million, marking a 37.05% increase year-on-year, with sales volume increasing by 41.43%[37]. - The company's operating revenue for the reporting period reached ¥965,398,173.72, a year-on-year increase of 42.46% compared to ¥677,675,002.99 in the same period last year[63]. - The company's operating costs increased by 45.30% to ¥763,590,666.09 from ¥525,512,212.97, primarily due to the growth in seed business revenue[63]. - The net cash flow from operating activities improved significantly, reaching ¥175,475,736.66, a 208.95% increase from a negative cash flow of -¥161,054,455.78 in the previous year[63]. Research and Development - Research and development expenses increased by 25% to 100 million CNY, focusing on biotechnology innovations[19]. - The company continues to focus on R&D for high-quality crop seeds, with R&D investments increasing over the years, reaching ¥83.28 million in 2021[38]. - The company has established a national agricultural technology innovation alliance, enhancing its research capabilities and collaboration with leading research institutions[38]. - The company has established close cooperation with multiple research institutions, including the Chinese Academy of Sciences and Zhejiang University, to enhance rice breeding innovation capabilities[41]. - The company added 8 new hybrid rice varieties approved at the provincial level and obtained 1 new invention patent and 19 plant variety rights during the reporting period, showcasing its strong research and development capabilities[51]. - The company has developed a total of 385 rice varieties (205 approved), 81 corn varieties (15 approved), and 15 wheat varieties, showcasing its strong research and development capabilities[56]. - The company has obtained 20 invention patents and 165 plant variety rights, indicating a robust innovation pipeline[56]. Market Expansion and Strategy - The company plans to launch three new seed varieties by the end of 2022, aiming to capture a larger market share[19]. - Future outlook includes a projected revenue growth of 10% for the second half of 2022, driven by increased demand in the agricultural sector[19]. - The company is expanding its market presence in Southeast Asia, with plans to establish two new distribution centers by Q4 2022[19]. - The company is actively expanding its market presence and enhancing its competitive edge through mergers and acquisitions, as well as collaborations with leading agricultural enterprises[48]. - The company is adapting its sales strategy to include a "company + large farmer" model to better serve growing customer segments[44]. - The company has implemented a sales model that includes both domestic and international markets, with a focus on dealer sales in China[44]. - The company is focused on integrating biotechnology and information technology to drive innovation in the seed industry, aligning with national agricultural modernization goals[48]. Risk Management - The management highlighted risks including intensified market competition and changes in agricultural policies that could impact operations[5]. - The company faces risks including capital turnover risk, product quality risk, and market fluctuation risk, which could impact its operational stability[47]. - The company has a robust risk management strategy in place for production, addressing potential impacts from natural conditions and management issues[41]. - The company emphasizes the importance of risk management in new business expansions, particularly in selecting reliable partners and ensuring contract compliance to mitigate market price fluctuations[130]. - The company is committed to maintaining a proactive approach in addressing potential risks associated with new product development and market demands[125]. Legal and Compliance Issues - The company is involved in ongoing litigation regarding the infringement of plant variety rights, with a claim for CNY 300 million in damages[166]. - The company is also engaged in a contract dispute regarding the use of rice varieties, seeking compensation of CNY 1.236 million[166]. - The company has ongoing litigation regarding a loan recovery of 538,010 CNY from 阿瓦提县广大农业科技开发有限公司[172]. - The company is currently involved in multiple lawsuits regarding intellectual property rights, including a case where it seeks 5 million yuan in damages for infringement of a new plant variety[187]. - The company has reported that several of its cases are currently under appeal, indicating ongoing legal challenges[185]. - The company is actively managing its legal disputes to mitigate financial impacts and ensure compliance with court rulings[182]. Corporate Governance and Social Responsibility - The company held two temporary shareholder meetings in 2022, with investor participation rates of 33.88% and 35.34% respectively[140]. - The company conducted 11 "Yuyue Action" charity events, benefiting 571 farmers and one village cooperative with agricultural materials valued at CNY 495,100[155]. - The company donated CNY 152,600 to two agricultural workers affected by significant family changes as part of the "Heli Xiangzhu" charity project[155]. - The company provided 200 bags of rice to frontline pandemic prevention workers in Hefei High-tech Zone, supporting public health efforts[155]. - The company donated CNY 48,000 worth of office computers and educational supplies to students in a remote area, enhancing educational resources[155]. - The company is focused on agricultural leadership and environmental protection, implementing dust control measures in seed processing[154].
荃银高科(300087) - 2022 Q1 - 季度财报
2022-04-26 16:00
Financial Performance - The company's revenue for Q1 2022 was CNY 440,361,052.90, representing a 49.66% increase compared to CNY 294,245,563.46 in the same period last year[4] - Net profit attributable to shareholders was CNY 20,415,502.56, a significant turnaround from a loss of CNY 2,071,685.35, marking an increase of 1,085.45%[4] - The net profit after deducting non-recurring gains and losses was CNY 17,314,536.66, compared to a loss of CNY 3,847,301.38, reflecting a 550.04% increase[4] - Basic and diluted earnings per share were both CNY 0.0459, a substantial increase from a loss of CNY 0.0048 per share in the same quarter last year, representing a 1,056.25% increase[4] - Net profit reached 29.86 million RMB, reflecting a significant growth of 815.37% year-on-year[20] - The company reported a net profit of approximately 439.34 million CNY, up from 418.93 million CNY, indicating an increase of about 4.9%[33] Cash Flow - The company's cash flow from operating activities showed a slight improvement, with a net outflow of CNY 119,969,801.96, down 2.70% from CNY 123,298,090.48 in the previous year[4] - Cash inflow from operating activities totaled CNY 509,233,962.90, a 32.31% increase from CNY 384,881,642.60 in the same period last year[11] - The net cash flow from operating activities was -$119.97 million, slightly improved from -$123.30 million year-over-year[44] - Cash outflow from operating activities totaled $629.20 million, compared to $508.18 million in the previous year[44] Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,312,081,322.34, down 6.40% from CNY 3,538,394,311.20 at the end of the previous year[4] - Total current assets amounted to approximately 2.50 billion CNY, down from 2.73 billion CNY in the previous period, reflecting a decrease of about 8.4%[24] - The company's cash and cash equivalents decreased from approximately 878.84 million CNY to about 587.78 million CNY, a decline of approximately 33%[24] - Total liabilities decreased from approximately 1.89 billion CNY to about 1.62 billion CNY, a reduction of about 14.3%[30] - The company's total assets decreased from approximately 3.54 billion CNY to about 3.31 billion CNY, reflecting a decline of about 6.5%[33] Shareholder Information - The total number of common stock shareholders at the end of the reporting period was 52,203[12] - The largest shareholder, China Seed Group Co., Ltd., holds 20.37% of shares, totaling 92,520,965 shares[12] - The second-largest shareholder, Jia Guilan, owns 6.87% of shares, amounting to 31,200,672 shares[12] Strategic Initiatives - The growth in performance is primarily driven by the continuous increase in seed business, particularly in hybrid rice and corn varieties[20] - The company has made progress in its strategic acquisition to enhance market share and competitiveness in the seed industry[23] - The company plans to acquire 60% of Xinjiang Jinfengyuan Seed Industry Co., Ltd. for a transaction price of 206.74 million CNY, reduced from the initial price of 213 million CNY[23] Board and Management - The company completed the election of the fifth board of directors and supervisory board on January 24, 2022[20] - The first meeting of the fifth board of directors was held on January 29, 2022, where key management positions were appointed[22] Investment and Research - The company reported a significant increase in investment income, amounting to CNY 2,688,492.20, up 848.70% from CNY 283,386.96 in the previous year[11] - Research and development expenses were ¥14,284,423.59, slightly up from ¥13,904,299.42, indicating continued investment in innovation[34]
荃银高科(300087) - 2021 Q4 - 年度财报
2022-03-28 16:00
Financial Performance - The company reported a total revenue of 1.2 billion CNY for the year 2021, representing a year-on-year increase of 15%[20] - The net profit attributable to shareholders was 150 million CNY, an increase of 10% compared to the previous year[20] - The company's operating revenue for 2021 was ¥2,520,772,778.56, representing a 57.38% increase compared to ¥1,601,709,079.85 in 2020[27] - The net profit attributable to shareholders for 2021 was ¥169,045,332.23, a 26.68% increase from ¥133,447,779.74 in 2020[27] - The net cash flow from operating activities improved significantly to ¥435,451,713.84, a 770.19% increase from -¥64,974,818.15 in 2020[27] - The total assets at the end of 2021 reached ¥3,538,394,311.20, up 43.11% from ¥2,472,447,760.58 at the end of 2020[27] - The basic earnings per share for 2021 was ¥0.39, a 21.88% increase compared to ¥0.32 in 2020[27] - The company achieved a revenue of CNY 252,077.28 million in 2021, representing a growth of 57.38% compared to the previous year[62] - The net profit attributable to shareholders reached CNY 16,904.53 million, an increase of 26.68% year-on-year[62] Market Expansion and Strategy - The company aims to expand its market presence by increasing its R&D investment by 20% in 2022 to enhance product innovation[20] - The company anticipates a revenue growth target of 12% for 2022, driven by new product launches and market expansion efforts[20] - The company is actively expanding its market presence and integrating domestic and international seed resources[41] - The company plans to expand overseas operations, particularly in Southeast Asia, South Asia, Africa, and Central Asia, while establishing local breeding bases to meet regional market demands[143] - The company aims to deepen its presence in domestic and "Belt and Road" markets, focusing on agricultural technology and value chain enhancement[142] Research and Development - The company invested in R&D with amounts of 55.44 million, 56.17 million, and 83.28 million CNY from 2019 to 2021, respectively, indicating a continuous commitment to innovation[45] - The company has established partnerships with three agricultural research institutions to accelerate the development of new technologies[20] - The company has a research team of 192 members, accounting for 18% of the total workforce, with significant academic and practical experience in breeding[56] - The company holds 19 invention patents and 146 plant variety rights, showcasing its strong research and innovation capabilities[56] - The company aims to enhance R&D in biological breeding technologies, increasing investment in cutting-edge technologies to improve seed quality and resistance[143] Product Development and Innovation - The company has launched three new seed varieties in 2021, contributing to a 25% increase in sales volume in the seed segment[20] - The company has developed 97 new or regionally approved varieties, including 92 rice varieties and 5 corn varieties, during the reporting period[62] - The company is focusing on the development of specialized grains for brewing, collaborating with various agricultural research institutions to support the industry[68] - The company is developing high-yield, disease-resistant rice varieties suitable for the Yangtze River Delta, with ongoing quality assessments[94] Risk Management and Challenges - The company faces risks related to market competition and changes in agricultural policies, which may impact future performance[5] - The company will strengthen standardized seed production bases to mitigate risks from climate change and natural disasters affecting seed quality and yield[147] - The company is committed to improving management capabilities across its 22 subsidiaries to adapt to changing business models and organizational structures[151] Corporate Governance and Management - The company maintains a governance structure that complies with relevant laws and regulations, ensuring a sound internal control system and risk management[159] - The board of directors consists of 9 members, including 4 independent directors, ensuring compliance with governance standards[162] - The financial department operates independently, maintaining a complete financial accounting system and separate bank accounts, ensuring no shared accounts with controlling shareholders[172] - The management team operates independently, ensuring that company decisions are implemented effectively and in line with strategic goals[164] Employee Engagement and Incentives - The company has implemented an employee stock ownership plan, which has effectively motivated employees and enhanced productivity[53] - The company has established contracts with regional seed production contractors, ensuring quality and compliance with production standards[48] Future Outlook - In 2022, the company plans to achieve revenue of 3 billion CNY and a net profit of 200 million CNY, with significant uncertainty due to market conditions[143] - The company has set a performance guidance of 1.5 billion RMB in revenue for 2022, reflecting a growth target of 25%[190] - The management team emphasized a focus on sustainable practices, aiming for a 30% reduction in carbon footprint by 2025[190]
荃银高科(300087) - 2021 Q3 - 季度财报
2021-10-27 16:00
Financial Performance - The company's revenue for Q3 2021 reached ¥521,490,868.06, representing a 61.22% increase year-over-year[4] - Net profit attributable to shareholders was ¥8,507,634.37, a significant increase of 272.08% compared to the same period last year[4] - The basic earnings per share for Q3 2021 was ¥0.0202, a 302.00% increase compared to the same period last year[4] - The company achieved operating revenue of 1,199.17 million RMB in 2021, representing a growth of 35.49% compared to the same period last year[24] - The net profit attributable to shareholders of the listed company was -0.96 million RMB, a decrease of 118.73% year-on-year[24] - The company's net profit for the period was a loss of ¥5,287,574.46, compared to a loss of ¥7,386,397.95 in the previous period, showing an improvement of approximately 28.4%[39] Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥482,912,394.58, showing a remarkable increase of 676.14%[4] - Cash inflow from operating activities totaled 1,870.09 million RMB, an increase of 45.23% due to higher cash receipts from sales[15] - Cash outflow from operating activities was 1,387.18 million RMB, a slight increase of 1.14% attributed to higher payments for goods[15] - The net cash flow from operating activities was 482.91 million RMB, a significant increase of 676.14% compared to the previous year[15] - The cash inflow from financing activities increased by 149.28% to 1,599.19 million RMB, primarily due to an increase in working capital loans[15] - The cash outflow for purchasing goods and services was 1,147,968,665.97, compared to 1,193,564,651.50 in the previous period[46] Assets and Liabilities - Total assets as of the end of Q3 2021 amounted to ¥3,483,973,293.07, reflecting a 40.91% increase from the end of the previous year[4] - The company's equity attributable to shareholders increased to ¥1,205,995,821.90, up 78.59% from the previous year[4] - The total liabilities increased significantly, with contract liabilities rising by 340.16% to ¥914,317,082.80, driven by increased customer deposits[10] - Total liabilities amounted to ¥2,078,733,067.37, up from ¥1,585,198,775.22, which is an increase of about 31.2%[35] - The company's total current assets reached ¥2.74 billion, up from ¥1.83 billion in the previous year, indicating a year-over-year increase of 49.8%[29] - The company's inventory stood at ¥909.69 million, slightly up from ¥893.16 million, reflecting a 1.8% increase[29] Investments and Financing - The company plans to use up to ¥1.79 billion of idle funds and up to ¥450 million of temporarily idle raised funds to purchase short-term financial products[26] - The company has signed a 15-year lease agreement for property with a transaction amount of ¥2.59 million, enhancing its operational capacity[26] - The company completed a private placement of 23,768,366 shares at a price of ¥23.14 per share, raising a net amount of approximately ¥536.92 million after expenses[26] - The company has increased its registered capital from ¥10 million to ¥30 million to support the development of its subsidiary, Shanghai Zhongke Quanyin Molecular Breeding Technology Co., Ltd.[26] Research and Development - Research and development expenses for the year-to-date period were ¥38,530,023.83, a 56.14% increase, indicating a commitment to enhancing innovation[11] - Research and development expenses increased to ¥38,530,023.83 from ¥24,676,803.88, reflecting a growth of about 56.1%[39] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 43,054[16] - The largest shareholder, Sinochem Modern Agriculture Co., Ltd., held 20.37% of the shares, totaling 92,520,965 shares[16] Future Plans - The company plans to continue expanding its seed business and increasing order volumes to drive future growth[24] - The company aims to acquire a 60% stake in Xinjiang Jinfengyuan Seed Industry Co., Ltd. for ¥21.3 million, which will become a subsidiary[26]
荃银高科(300087) - 2021 Q2 - 季度财报
2021-08-25 16:00
Financial Performance - The company's operating revenue for the first half of 2021 was ¥677,675,002.99, representing a 20.66% increase compared to ¥561,624,439.20 in the same period last year[26]. - The net profit attributable to shareholders of the listed company was -¥9,466,849.41, a decrease of 194.05% from ¥10,066,201.86 in the previous year[26]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥11,917,329.04, which is a 69.67% decline compared to -¥7,023,993.25 in the same period last year[26]. - The net cash flow from operating activities improved to -¥161,054,455.78, a 56.45% increase from -¥369,811,846.24 in the previous year[26]. - The total assets at the end of the reporting period were ¥2,457,385,559.40, a decrease of 0.61% from ¥2,472,447,760.58 at the end of the previous year[26]. - The net assets attributable to shareholders of the listed company decreased by 4.23% to ¥646,709,983.39 from ¥675,300,719.30 at the end of the previous year[26]. - The basic and diluted earnings per share were both -¥0.02, reflecting a 200.00% decline from ¥0.02 in the same period last year[26]. - The weighted average return on net assets was 1.25%, down from 2.08% in the previous year[26]. Research and Development - The company maintained a high level of R&D investment, with amounts of CNY 62.66 million, CNY 55.44 million, and CNY 56.17 million for the years 2018, 2019, and 2020 respectively[36]. - The company has established a breeding system with a focus on independent research and development, collaborating with domestic research institutions and universities[36]. - The company has formed a "National Rice Commercial Molecular Breeding Technology Innovation Alliance" to enhance research and development capabilities in crop breeding[36]. - The company has built stable research and breeding bases in multiple locations, including Hefei and Sanya, to support its R&D efforts[36]. - The company has been recognized as a "National Enterprise Technology Center" and has established various research facilities, including a postdoctoral research station and an engineering technology research center[36]. - The company’s breeding process involves determining breeding directions based on market demand and selecting high-quality parent materials[36]. - The company’s research and development strategy relies on its own capabilities while collaborating with external partners to enhance its breeding programs[43]. - The company has developed a strong research and innovation capability, with 186 research personnel, accounting for 18.9% of total employees, and has secured 15 invention patents and 96 plant variety rights[51]. - The company has established various innovation platforms, including a "National Enterprise Technology Center" and a "Key Laboratory for Hybrid Rice Variety Creation," enhancing its research capabilities[51]. - The company has a diverse portfolio of seed varieties, with a total of 259 rice varieties (125 nationally approved), 67 corn varieties (10 nationally approved), and 8 wheat varieties, showcasing its strong R&D output[51]. Market and Sales - The increase in operating revenue was primarily due to enhanced marketing efforts and increased seed sales volume[47]. - The company’s order agriculture business scale has expanded, contributing to revenue growth[47]. - The company sold 15.1143 million kilograms of various crop seeds, a year-on-year increase of 27.95%, with rice seed sales volume increasing by 13.59% and sales revenue increasing by 25.92%[62]. - The company introduced 29 new provincial-approved varieties, including 17 rice, 6 corn, and 6 wheat varieties during the reporting period[60]. - The company is focusing on a "company + large households" marketing model to adapt to the increasing number of large-scale farmers and cooperatives[42]. - The company emphasizes strict quality control during the procurement of agricultural products to meet market standards[46]. - The company is actively expanding its market presence both domestically and internationally, with significant achievements in seed exports and overseas agricultural technology development[53]. - The company has been involved in foreign aid projects in countries like Angola and Sierra Leone, leveraging international opportunities to enhance its competitive edge[56]. Risks and Challenges - The company faces risks including intensified market competition and challenges in new variety research and promotion[6]. - The decrease in net profit was mainly due to the amortization of the new employee stock ownership plan amounting to 27.4275 million yuan; excluding this factor, net profit increased by 78.43% year-on-year[47]. - The company faces intensified market competition due to the implementation of new seed laws and rapid introduction of new varieties, leading to significant inventory pressure and potential market share loss if it fails to innovate and expand[103]. - Seed production is highly sensitive to climate conditions, with recent climate changes increasing the risk of natural disasters affecting seed yield and quality, prompting the company to enhance standardized production practices[105]. - The company is committed to increasing research investment and innovation capabilities to mitigate risks associated with potential changes in national agricultural policies that could impact seed development and sales[106]. Legal and Compliance - The company is currently involved in a lawsuit where it is required to pay 16,423,752,000 VND (approximately 4,856,503 RMB) in compensation due to alleged seed quality issues[138]. - The company has ongoing litigation regarding overdue rental payments totaling 1,134,306.30 RMB from various tenants[138]. - The company has been involved in multiple legal disputes, reflecting challenges in its operational environment and potential impacts on cash flow[138]. - The company is actively managing its legal risks and disputes, which may impact its operational focus and financial performance[141]. - The company is pursuing a claim for 500 million CNY against Anhui Ansheng Seed Co. for infringement of plant variety rights, with the case currently pending in court[149]. - The company has engaged in related party transactions, including seed procurement from Syngenta Group, amounting to 5.56 million CNY, which is 0.02% of the total related transactions[155]. Corporate Governance and Social Responsibility - The company has not faced any administrative penalties related to environmental issues during the reporting period[121]. - The company actively engaged in social responsibility through the Anhui Zhang Haiyin Seed Industry Foundation, awarding 23 seed industry elites and providing scholarships to 10 outstanding students[122]. - The "Suiyue Action" initiative supported 1,503 farmers in five provinces with donations of seeds and fertilizers, contributing to rural revitalization efforts[122]. - The company has not reported any significant changes in agricultural tax incentives, government subsidies, or industrial policies affecting the company during the reporting period[180]. - The company is committed to maintaining its market position despite ongoing legal challenges, indicating resilience in its business strategy[138].
荃银高科(300087) - 2021 Q1 - 季度财报
2021-04-27 16:00
Financial Performance - The company's operating revenue for Q1 2021 was ¥294,245,563.46, representing a 66.13% increase compared to ¥177,119,593.81 in the same period last year[8]. - The net profit attributable to shareholders was -¥2,071,685.35, a decrease of 123.48% from ¥8,822,859.72 in the previous year[8]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥3,847,301.38, down 147.34% from ¥8,127,251.78 year-on-year[8]. - The basic earnings per share for the reporting period was -¥0.0048, a decline of 122.43% from ¥0.0214 in the same period last year[8]. - The diluted earnings per share for the reporting period was also -¥0.0048, reflecting the same percentage decline as basic earnings per share[8]. - The net profit for Q1 2021 was CNY -4.17 million, a decrease of CNY 0.98 million from the previous year[28]. - The net profit for the period was a loss of ¥4,174,272.06, contrasting with a net profit of ¥5,612,365.78 in the same period last year, reflecting a decline of approximately 174.4%[71]. - The total comprehensive income for the current period is -¥4,687,334.17, down from ¥12,899,338.53 in the previous period[78]. Cash Flow - The net cash flow from operating activities was -¥123,298,090.48, an improvement of 31.75% compared to -¥180,646,691.55 in the same period last year[8]. - The company's cash inflow from operating activities totaled CNY 384.88 million, up 74.23% from CNY 220.90 million in Q1 2020[24]. - The cash outflow from operating activities increased by 26.55% to CNY 508.18 million, compared to CNY 401.55 million in Q1 2020[24]. - The company reported a significant increase in cash received from investment activities, totaling ¥156,960,000.00 compared to ¥146,192,246.42 in the previous period[87]. - Net cash flow from operating activities was CNY -75,114,083.84, improving from CNY -163,666,583.76 year-over-year[92]. - Net cash flow from investment activities was CNY 20,558,725.39, a recovery from CNY -16,850,831.39 in the previous year[95]. - Financing cash inflow amounted to CNY 270,050,000.00, down from CNY 440,392,305.20 in the last period[92]. - The ending cash and cash equivalents balance was CNY 228,778,530.93, a decrease from CNY 444,376,054.14 year-over-year[92]. Assets and Liabilities - The total assets at the end of the reporting period were ¥2,311,572,621.53, a decrease of 6.51% from ¥2,472,447,760.58 at the end of the previous year[8]. - As of March 31, 2021, the total current assets amounted to ¥1,651,980,883.46, a decrease of approximately 9.75% from ¥1,830,402,617.25 as of December 31, 2020[49]. - Cash and cash equivalents decreased to ¥230,909,386.65 from ¥437,522,550.22, representing a decline of about 47.3%[49]. - The company's total liabilities decreased to ¥1,411,087,157.69 from ¥1,585,198,775.22, a decline of approximately 10.9%[55]. - Current liabilities decreased significantly to ¥1,118,400,702.33 from ¥1,531,475,816.01, a reduction of about 27.0%[55]. - Total liabilities decreased to ¥1,015,450,557.22 from ¥1,175,813,530.46, representing a decline of approximately 13.6%[65]. - The total equity attributable to shareholders increased to ¥685,494,638.48 from ¥675,300,719.30, reflecting a growth of about 1.8%[58]. Research and Development - The company's research and development expenses increased by 53.84% to CNY 13.90 million, reflecting a commitment to enhancing R&D efforts[23]. - Research and development expenses totaled ¥13,904,299.42, up from ¥9,038,309.30, marking an increase of about 54.5% year-over-year[68]. - The company plans to enhance R&D investment and accelerate the development of new varieties to meet market demand, while also improving marketing strategies and expanding sales networks[31]. - The company acknowledges risks associated with new variety development, including long cycles and high investment, and aims to ensure market-oriented R&D[31]. Market and Competition - The company has faced intensified market competition due to the implementation of the new Seed Law, leading to a significant influx of new varieties and increased inventory pressure[31]. - The company is focused on mitigating risks from potential changes in industry policies by increasing R&D investment and ensuring high-quality seed production[31]. - The company is addressing production risks related to climate sensitivity by strengthening standardized seed production bases and improving production management[31]. Shareholder and Corporate Structure - The largest shareholder, Sinochem Modern Agriculture, acquired control of the company with 127,926,927 shares, representing 29.73% of total shares after a voting rights delegation agreement[35]. - The company has established a group structure with 19 subsidiaries and 4 associated companies, necessitating improvements in management capabilities across various functions[31]. - Shareholder Jia Guilan released the pledge on 10,200,000 shares, while Zhang Qin released the pledge on 10,085,154 shares and pledged 750,000 shares[35]. - During the reporting period, the company’s vice chairman and general manager Zhang Qin reduced her holdings by 3,301,600 shares, and other executives also reduced their holdings[35]. Compliance and Governance - The company reported no violations regarding external guarantees during the reporting period[43]. - There were no non-operational fund occupations by controlling shareholders or related parties during the reporting period[44]. - The company did not conduct any research, communication, or interview activities during the reporting period[45]. - The company has not undergone an audit for the first quarter report[108]. - The company has not made any adjustments related to the new leasing standards for prior comparative data[105].
荃银高科(300087) - 2020 Q4 - 年度财报
2021-04-22 16:00
Financial Performance - The company reported a total revenue of 1.2 billion CNY for the year 2020, representing a year-on-year increase of 15%[18]. - The net profit attributable to shareholders was 150 million CNY, an increase of 20% compared to the previous year[18]. - The company's operating revenue for 2020 was ¥1,601,709,079.85, representing a 38.84% increase compared to ¥1,153,661,613.91 in 2019[24]. - The net profit attributable to shareholders for 2020 was ¥133,447,779.74, up 41.10% from ¥94,577,409.98 in 2019[24]. - The company achieved a revenue of 1,601.71 million yuan, representing a growth of 38.84% compared to the previous year[48]. - The net profit attributable to shareholders reached 133.45 million yuan, an increase of 41.10% year-on-year[48]. - The company reported a significant increase in costs, with agricultural costs rising by 53.01% year-on-year[92]. - The total revenue for 2020 reached ¥1,601,709,079.85, a 38.84% increase from ¥1,153,661,613.91 in 2019[88]. - The company’s agricultural production volume increased by 150.66%, reaching 486,958,970.93 kg in 2020[96]. - The company reported a net profit attributable to shareholders of RMB 133,447,779.74 for the year 2020[174]. Dividend Policy - The company plans to distribute a cash dividend of 1 CNY per 10 shares, totaling approximately 42.14 million CNY based on the adjusted share capital[6]. - The total distributable profit for the year 2020 was RMB 300,302,781.40, after deducting the legal surplus reserve and previous undistributed profits[174]. - The company proposed a cash dividend of RMB 1.00 per 10 shares, totaling RMB 42,136,583.50, with no stock dividends or capital reserve transfers planned for 2020[175]. - The cash dividend represents 100% of the total profit distribution for the year, indicating a strong commitment to returning value to shareholders[173]. - The company’s cash dividend payout ratio for 2020 was 47.02% of the net profit attributable to shareholders[178]. Research and Development - The company has invested 200 million CNY in R&D for new seed varieties and technologies in 2020, aiming to enhance product competitiveness[18]. - The company focuses on the research, breeding, promotion, and service of high-quality seeds for major crops such as rice, corn, and wheat, with a commitment to integrating research and market needs[37]. - Research and development investment from 2018 to 2020 was maintained at a high level, with amounts of 62.66 million, 55.44 million, and 56.17 million yuan respectively[37]. - The company has established partnerships with several research institutions to enhance its breeding capabilities and accelerate the commercialization of research outcomes[37]. - The company has developed a total of 242 rice varieties, 61 corn varieties, 2 wheat varieties, 6 cotton varieties, and 4 rapeseed varieties, with 125 rice varieties approved at the national level[67]. Market Expansion - The company aims to expand its market presence in Southeast Asia, targeting a 25% increase in export sales by 2022[18]. - The company is actively exploring international markets and increasing its "going out" strategy to participate in global competition[49]. - The company has established 17 rice or corn varieties that have been approved in countries such as Bangladesh, Angola, and Indonesia, laying the foundation for future sales[76]. - The company is implementing an overseas "breeding, propagation, and promotion integration" strategy, with plans to establish bases in Angola and Bangladesh[76]. - The company is expanding its market presence internationally, with significant assets in Angola, including cash and receivables totaling ¥33,499.68 and ¥4,469,777.06 respectively[54]. Risk Management - The company faces risks related to intensified market competition and changes in agricultural policies, which may impact future performance[6]. - The company is facing risks related to market fluctuations and product quality, necessitating strict quality control measures[47]. - The company has a risk-sharing mechanism in place for production losses due to natural conditions, which involves collaboration among the company, seed producers, and farmers[40]. - The company acknowledges risks associated with new variety development, including long cycles and high investment, and will focus on market-oriented research[156]. - The company is addressing production risks related to climate sensitivity by enhancing standardized seed production bases and improving management practices[159]. Strategic Initiatives - The company is exploring potential mergers and acquisitions to enhance its supply chain efficiency and market reach[18]. - The company is implementing an "order agriculture" business model, integrating resources to enhance market competitiveness and promote seed sales[44]. - The company is actively pursuing mergers and acquisitions to accelerate its five-year strategic plan and enhance its competitive position in the seed industry[155]. - The company has initiated a refinancing plan to support its overseas agricultural seed projects[76]. - The company has implemented a five-year strategic plan to address challenges and opportunities, clarifying its future development direction[81]. Employee Engagement - The company is leveraging employee stock ownership plans to boost employee motivation and engagement[48]. - The company has implemented a stock incentive plan since 2014, significantly enhancing employee motivation and contributing to performance growth[62]. - The company launched an employee stock ownership plan covering nearly 300 key personnel to align interests and enhance performance[83]. Corporate Social Responsibility - The company donated 1 million yuan to support COVID-19 prevention efforts and contributed to poverty alleviation projects across multiple provinces[84]. - The company is committed to enhancing its industry influence and brand recognition while contributing to national food security and rural revitalization strategies[86].
荃银高科(300087) - 2020 Q3 - 季度财报
2020-10-29 16:00
Financial Performance - Operating revenue for the reporting period was CNY 323,458,854.27, representing a year-on-year increase of 216.68%[8] - The company reported a total net profit of CNY 5,122,119.07 for the year-to-date, an increase of 117.75% compared to the same period last year[8] - The net profit attributable to shareholders was a loss of CNY 4,944,082.73, a slight increase of 1.85% compared to the same period last year[8] - The company reported a decrease in employee compensation payable to CNY 7,010,465.17 from CNY 38,553,749.38, a reduction of approximately 82%[46] - The net profit for Q3 2020 was a loss of CNY 10,939,836.30, an improvement compared to a loss of CNY 41,974,268.05 in the previous year[57] - The company reported a financial expense of CNY 8,099,365.67, compared to a financial income of CNY 138,159.43 in the previous year, indicating a shift in financial performance[55] - The net profit attributable to the parent company was 5,122,119.07 CNY, compared to a net loss of 28,864,693.07 CNY in the same period last year, indicating a significant recovery[68] Assets and Liabilities - Total assets at the end of the reporting period reached CNY 2,452,289,535.01, an increase of 41.78% compared to the end of the previous year[8] - Total liabilities increased significantly, with short-term borrowings rising by 710.15% to RMB 630,000,000.00, indicating increased working capital loans[20] - Total liabilities reached CNY 1,838,050,862.18, up from CNY 1,085,462,881.35, indicating a growth of about 69%[46] - The company's equity attributable to shareholders decreased slightly to CNY 480,399,267.56 from CNY 481,529,122.97, a decline of about 0.2%[48] - The company's current assets totaled CNY 1,984,558,866.27, up from CNY 1,286,862,690.00 in December 2019, indicating a growth of about 54%[42] Cash Flow - The net cash flow from operating activities was CNY 285,993,212.48, a decrease of 6.02% compared to the previous period[8] - The net cash flow from operating activities was significantly higher than the previous year, indicating improved operational efficiency and cash generation capabilities[76] - The net cash flow from operating activities was -¥83,818,633.76, a significant decline compared to ¥74,870,930.04 in the previous year[78] - The total cash outflow from operating activities reached ¥1,371,504,823.81, up from ¥641,057,309.91 year-over-year[78] - The net cash flow from financing activities was ¥516,513,387.00, a turnaround from -¥85,940,300.10 in the previous year[80] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 25,970[11] - The largest shareholder, Sinochem Modern Agriculture Co., Ltd., held 21.50% of the shares, totaling 92,520,965 shares[11] - Major shareholders have reduced their holdings by a total of 23,826,371 shares from March to September 2020[27] - The company plans to reduce its shares by up to 3,000,000 shares by major shareholders, with 2,046,900 shares already reduced by one shareholder[23] Government Support and Investments - The company received government subsidies amounting to CNY 22,473,562.06 during the reporting period[10] - Other income surged by 266.92% to RMB 22,473,562.06, primarily due to increased government subsidies[22] - The company intends to raise up to RMB 60 million through a private placement to fund various projects, including R&D and overseas seed breeding initiatives[25] Research and Development - Research and development expenses for the quarter were CNY 5,684,805.64, a decrease from CNY 13,165,710.81 in the same period last year[55] - Research and development expenses amounted to 9,691,350.95 CNY, up from 7,989,278.57 CNY in the previous year, indicating a focus on innovation and product development[71] Strategic Initiatives - The company plans to establish a joint venture with a registered capital of RMB 26.25 million, contributing RMB 18 million, to enhance its competitiveness in the southwest rice seed market[25] - The company signed a framework agreement with Sinochem Modern Agriculture Anhui Co., Ltd. for the procurement of rice seeds worth RMB 27 million from September 2020 to August 2023[23] - The company has established a joint venture named Sichuan QuanYin Biotechnology Co., Ltd. with the local government, focusing on integrated breeding and promotion projects[30] Compliance and Governance - The company reported no violations regarding external guarantees during the reporting period[37] - The company has not experienced any non-operating fund occupation by controlling shareholders or related parties during the reporting period[38] - The company has completed the share reduction plan for major shareholders and executives, with relevant announcements made[30]
荃银高科(300087) - 2020 Q2 - 季度财报
2020-08-26 16:00
Financial Performance - The company's operating revenue for the first half of 2020 was CNY 561,624,439.20, representing a 161.35% increase compared to CNY 214,895,456.02 in the same period last year[23]. - The net profit attributable to shareholders of the listed company was CNY 10,066,201.86, a significant turnaround from a loss of CNY 4,221,806.87 in the previous year, marking a 338.43% increase[23]. - Basic earnings per share increased to CNY 0.02 from a loss of CNY -0.01, reflecting a 300.00% improvement[23]. - The company reported a decrease in net profit after deducting non-recurring gains and losses to CNY -7,023,993.25, an improvement of 57.08% from CNY -16,364,224.40 in the previous year[23]. - The weighted average return on net assets was 2.08%, a recovery from -0.53% in the same period last year, indicating improved profitability[23]. - The company achieved a revenue of 561.62 million yuan, representing a year-on-year growth of 161.35%[47]. - The net profit attributable to shareholders was 10.07 million yuan, marking a turnaround from loss to profit compared to the previous year[47]. - The increase in seed sales and order grain business revenue contributed to the growth in gross profit[47]. - The company received increased government subsidies compared to the previous year, further supporting its financial performance[47]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,033,665,761.81, up 17.57% from CNY 1,729,688,942.68 at the end of the previous year[23]. - The net assets attributable to shareholders of the listed company were CNY 485,343,740.26, a slight increase of 0.79% from CNY 481,529,122.97 at the end of the previous year[23]. - The company reported a significant increase in equity assets, with a balance of ¥2,068,946.04, up by ¥1,721,825.46 compared to the beginning of the period, primarily due to capital increase in its subsidiary Guangdong Jingu Qianyuan Company[52]. - Cash and cash equivalents at the end of the reporting period amounted to ¥314,506,635.06, representing 15.47% of total assets[81]. - Accounts receivable increased to ¥258,302,896.90, accounting for 12.70% of total assets, attributed to the growth in order grain business[81]. - Short-term borrowings rose significantly to ¥630,000,000.00, making up 30.98% of total liabilities, due to increased working capital loans[81]. Research and Development - The company has maintained a high level of R&D investment, with R&D expenses accounting for 4.77%, 6.88%, and 4.81% of revenue from 2017 to 2019[33]. - The company focuses on the research and development of high-quality seeds for major crops, including hybrid rice, corn, and wheat, with sales covering key agricultural regions in China and overseas markets[32]. - The breeding cycle for new varieties typically takes 8-10 years, but can be shortened to 3-4 years using molecular breeding techniques[37]. - The company has established a national innovation alliance for rice molecular breeding, recognized as a benchmark alliance by the Ministry of Agriculture and Rural Affairs[33]. - The company has developed a total of 169 rice varieties, including 74 national approved varieties, and 50 corn varieties, with 5 national approved[60]. - The company has received 11 invention patents and 64 plant variety rights, showcasing its strong research and innovation capabilities[60]. - The company has established multiple innovation platforms, including a "National Enterprise Technology Center" and an "Anhui Provincial Engineering Research Center" to enhance its R&D capabilities[59]. - The company has formed strategic partnerships with leading agricultural research institutions to enhance its breeding technology and product development[60]. Market Strategy and Operations - The company actively explores order agriculture business to enhance its market presence and agricultural development[32]. - The company’s breeding program is driven by market demand, focusing on high-yield and stress-resistant parent lines[34]. - The company adopted a "company + base + farmers" model for seed production, ensuring quality through a structured process[38]. - The sales model includes a direct supply channel to large agricultural operators, enhancing service-oriented marketing[42]. - The company is exploring order agriculture to integrate resources and promote brand grain production, enhancing market competitiveness[43]. - The company is positioned to benefit from the ongoing structural reforms in agriculture, focusing on quality improvement and faster variety updates in seed production[51]. - The company is expanding its market presence in Southeast Asia, targeting a 25% market share by the end of 2021[182]. Risks and Challenges - The company faces risks including intensified market competition and challenges in new variety research and promotion[6]. - Risks in the production process include natural conditions affecting seed quality and yield, which are shared among the company, seed producers, and farmers[38]. - The company plans to mitigate market fluctuation risks by collaborating with large, reputable enterprises and ensuring contract compliance[46]. - The company is exposed to risks related to new variety R&D, including long cycles and high costs, with uncertainties in market acceptance and potential natural disasters affecting performance[108]. - The company aims to strengthen standardized seed production bases and improve production management to mitigate risks from climate change and pest outbreaks[108]. - The company is at risk from potential changes in national agricultural policies that could impact seed R&D, production, and sales[108]. Corporate Governance and Shareholder Matters - The company declared a cash dividend of 0.5 yuan per 10 shares, totaling 20,609,791.75 yuan (after tax) for 412,195,835 shares[117]. - The total distributable profit for the period was 159,487,271.64 yuan, with the cash dividend representing 100% of the profit distribution[117]. - The company did not issue any bonus shares or conduct capital reserve transfers to increase share capital during the reporting period[117]. - The company held three temporary shareholder meetings and one annual shareholder meeting, with participation rates of 38.97%, 17.43%, 40.13%, and 48.91% respectively[114]. - There were no major litigation or arbitration matters during the reporting period[123]. - The company has not undergone any bankruptcy reorganization during the reporting period[122]. - The semi-annual financial report was not audited[121]. Social Responsibility and Environmental Initiatives - The company actively engaged in social responsibility initiatives, donating over CNY 1 million to support pandemic relief and poverty alleviation efforts[73]. - The company emphasized environmental protection and does not belong to the key pollutant discharge units as per environmental protection department announcements[166]. - The company has implemented measures to reduce pollution from dust during seed selection processes[168]. - The company participated in the "Suiyue" targeted poverty alleviation initiative, donating over RMB 1 million worth of seeds, fertilizers, and funds to 1,810 registered impoverished households across seven provinces[170]. - The company provided RMB 2 million in scholarships and support to 10 impoverished students during the Dragon Boat Festival[171]. - The company plans to continue its targeted poverty alleviation efforts, integrating national poverty alleviation strategies with its own development strategies[172]. Related Transactions and Financial Agreements - The company signed a three-year financial service agreement with Sinochem Group Finance Co., Ltd., with a maximum amount involved not exceeding RMB 3,010 million[158]. - As of the reporting period, the company's deposit balance with the financial company was RMB 1,981,178.79, and the loan balance was RMB 430,000,000[158]. - The company signed a related party transaction for the procurement of rice seeds with a total transaction amount of RMB 2,809,000[186]. - The company approved financial support of up to RMB 80 million to its subsidiary for grain and crop seed operations, with a borrowing rate 1% above the bank's benchmark rate[186]. - The company used its own funds of RMB 140.08 million to acquire 40% equity of its subsidiary, making it a wholly-owned subsidiary[186]. - The company acquired 46% equity of its subsidiary for RMB 161.46 million, resulting in it becoming a wholly-owned subsidiary[186].